สหภาพยุโรป - สวีเดน - EMA (European Medicines Agency)

novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - andra antineoplastiska medel - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.

สหภาพยุโรป - สวีเดน - EMA (European Medicines Agency)

accord healthcare s.l.u. - plerixafor - multiple myeloma; hematopoietic stem cell transplantation - immunstimulatorer, - adult patientsplerixafor accord is indicated in combination with granulocyte-colony stimulating factor (g-csf) to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in adult patients with lymphoma or multiple myeloma whose cells mobilise poorly (see section 4. paediatric patients (1 to less than 18 years)plerixafor accord is indicated in combination with g-csf to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in children with lymphoma or solid malignant tumours, either:- pre-emptively, when circulating stem cell count on the predicted day of collection after adequate mobilization with g-csf (with or without chemotherapy) is expected to be insufficient with regards to desired hematopoietic stem cells yield, or- who previously failed to collect sufficient haematopoietic stem cells (see section 4.

สวีเดน - สวีเดน - Läkemedelsverket (Medical Products Agency)

medical valley invest ab - bisoprololfumarat - filmdragerad tablett - 2,5 mg - bisoprololfumarat 2,5 mg aktiv substans

สวีเดน - สวีเดน - Läkemedelsverket (Medical Products Agency)

medical valley invest ab - bisoprololfumarat - filmdragerad tablett - 3,75 mg - bisoprololfumarat 3,75 mg aktiv substans

สวีเดน - สวีเดน - Läkemedelsverket (Medical Products Agency)

medical valley invest ab - bisoprololfumarat - filmdragerad tablett - 7,5 mg - bisoprololfumarat 7,5 mg aktiv substans

สวีเดน - สวีเดน - Läkemedelsverket (Medical Products Agency)

medical valley invest ab - bisoprololfumarat - filmdragerad tablett - 1,25 mg - bisoprololfumarat 1,25 mg aktiv substans

สวีเดน - สวีเดน - Läkemedelsverket (Medical Products Agency)

accord healthcare b.v. - vildagliptin - tablett - 50 mg - laktos (vattenfri) hjälpämne; vildagliptin 50 mg aktiv substans

สวีเดน - สวีเดน - Läkemedelsverket (Medical Products Agency)

orifarm ab - buserelinacetat - implantat - 9,45 mg - buserelinacetat 9,9 mg aktiv substans - buserelin

สวีเดน - สวีเดน - Läkemedelsverket (Medical Products Agency)

orifarm ab - buserelinacetat - implantat - 9,45 mg - buserelinacetat 9,9 mg aktiv substans - buserelin

สวีเดน - สวีเดน - Läkemedelsverket (Medical Products Agency)

orifarm ab - buserelinacetat - implantat - 9,45 mg - buserelinacetat 9,9 mg aktiv substans - buserelin